Video: Boosting the efficacy and reducing the toxicity of the chemotherapy drug methotrexate


July 11, 2018

Tags: Sabatini Lab CancerProtein Function

Naama Kanarek, a postdoctoral researcher in the lab of Whitehead Member David Sabatini, explains how new genetic tools are allowing insights into the sensitivity of cancer cells to methotrexate and discusses how research might help address some of the challenges of methotrexate chemotherapy treatment.

© Whitehead Institute for Biomedical Research              455 Main Street          Cambridge, MA 02142